Related Experiment Videos
Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema
Danish Medical Bulletin
|December 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.
European journal of cancer (Oxford, England : 1990)·2007
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.
European journal of cancer (Oxford, England : 1990)·2006
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
Pain and convalescence following laparoscopic ventral hernia repair.
Danish medical bulletin·2011
Communication with patients and colleagues.
Danish medical bulletin·2011
Short convalescence and minimal pain after out-patient Bascom's pit-pick operation.
Danish medical bulletin·2011
Cancer immunoediting in the melanoma tumor microenvironment: from immune elimination to therapeutic resistance.
Frontiers in immunology·2026
Immune remodeling of tumor-draining lymph nodes: mechanistic determinants of checkpoint blockade responsiveness.
Frontiers in immunology·2026
Lymph node lymphatic PD-L1 regulates tumor-infiltrating T cells in immune checkpoint-sensitive melanoma.
Cancer research communications·2026
Breast cancer immunogenicity as a spectrum: evolving concepts and therapeutic implications.
The Journal of clinical investigation·2026